519 672 2121
Close mobile menu
Published on: 21 Sep 2023 By
Video Icon

Understanding privacy impact assessments (PIAs) and their importance for your business

In the ever-evolving data privacy landscape, businesses must stay ahead of the curve to protect themselves and their customers. One crucial tool that can help you navigate this complex terrain is a privacy impact assessment, or PIA. What is a privacy impact assessment (PIA)? Privacy impact a…

View the post titled Understanding privacy impact assessments (PIAs) and their importance for your business
Published on: 12 Sep 2023 By

What qualifies as an “accident” under the Statutory Accident Benefits Schedule?

Statutory Accident Benefits (SABS) provides financial support to individuals involved in accidents that are covered under a car insurance policy. It is essential to have a clear understanding of what constitutes an accident in order to determine one’s eligibility for these benefits. What exa…

View the post titled What qualifies as an “accident” under the Statutory Accident Benefits Schedule?
Published on: 23 Aug 2023 By

Ozempic for weight loss? Know the risks of off-label prescriptions

Ozempic (semaglutide) is a prescription drug approved to treat type 2 diabetes that has become one of the most in-demand medications in North America in recent years. Demand for Ozempic, which is manufactured by Novo Nordisk, has driven shortages in the United States. Health Canada observed …

View the post titled Ozempic for weight loss? Know the risks of off-label prescriptions
Published on: 9 Aug 2023 By

Bladder drug Elmiron – linked to vision loss, macular degeneration – still among top non-patented drugs in Canada per 2023 report

Elmiron, a medication prescribed for bladder issues that has been linked to a unique form of macular degeneration causing vision loss, continues to rank among the top publicly funded non-patented drugs in Canada, according to a government report on public drug plan expenditures published ear…

View the post titled Bladder drug Elmiron – linked to vision loss, macular degeneration – still among top non-patented drugs in Canada per 2023 report
Published on: 3 Aug 2023 By

Legal costs in Ontario: How they’re awarded and what it means for litigants

When our clients become involved in litigation, one of the first questions they often ask us is, “Can I claim my legal expenses?” While every claim is different, typically costs follow the event in Ontario. This means that, at the conclusion of trial, the successful party can expect the judg…

View the post titled Legal costs in Ontario: How they’re awarded and what it means for litigants
Published on: 3 Aug 2023 By

Going to court in Ontario: Overview of a motion in a commercial litigation dispute

What is a motion? A motion is a court procedure used to resolve an interim dispute within your legal case. A motion can be brought within a legal action or a legal application. It is used to resolve procedural or substantive issues. Motions can be small and simple or large and complex. For e…

View the post titled Going to court in Ontario: Overview of a motion in a commercial litigation dispute
Published on: 1 Aug 2023 By

Ontario Court of Appeal decides non-party litigation funders not liable for defendants’ costs in Davies v. Clarington (Municipality)

In Davies v. Clarington (Municipality), 2023 ONCA 376, the Ontario Court of Appeal reached the reasonable conclusion that non-party lenders with no involvement in directing litigation are not liable to pay an adverse costs award that a plaintiff will not pay.  On this appeal, the Court provi…

View the post titled Ontario Court of Appeal decides non-party litigation funders not liable for defendants’ costs in Davies v. Clarington (Municipality)